These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 30968973

  • 1. Hypobaric hypoxia regulates iron metabolism in rats.
    Li Y, Zhou Y, Zhang D, Wu WY, Kang X, Wu Q, Wang P, Liu X, Gao G, Zhou Y, Wang G, Chang YZ.
    J Cell Biochem; 2019 Aug; 120(8):14076-14087. PubMed ID: 30968973
    [Abstract] [Full Text] [Related]

  • 2. Sex differences in iron status and hepcidin expression in rats.
    Kong WN, Niu QM, Ge L, Zhang N, Yan SF, Chen WB, Chang YZ, Zhao SE.
    Biol Trace Elem Res; 2014 Aug; 160(2):258-67. PubMed ID: 24962641
    [Abstract] [Full Text] [Related]

  • 3. Hypobaric Hypoxia Regulates Brain Iron Homeostasis in Rats.
    Li Y, Yu P, Chang SY, Wu Q, Yu P, Xie C, Wu W, Zhao B, Gao G, Chang YZ.
    J Cell Biochem; 2017 Jun; 118(6):1596-1605. PubMed ID: 27925282
    [Abstract] [Full Text] [Related]

  • 4. Chronic intermittent hypobaric hypoxia improves iron metabolism disorders via the IL-6/JAK2/STAT3 and Epo/STAT5/ERFE signaling pathways in metabolic syndrome rats.
    Cui F, Sun J, Mi H, Li B, Tang L, Wang R, Du Y, Guo B, Li Y, Shi M.
    J Trace Elem Med Biol; 2023 Sep; 79():127259. PubMed ID: 37413927
    [Abstract] [Full Text] [Related]

  • 5. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
    Pirotte M, Fillet M, Seidel L, Jaspers A, Baron F, Beguin Y.
    Am J Hematol; 2021 Oct 01; 96(10):1275-1286. PubMed ID: 34310730
    [Abstract] [Full Text] [Related]

  • 6. Vitamin A deficiency modulates iron metabolism via ineffective erythropoiesis.
    da Cunha MS, Siqueira EM, Trindade LS, Arruda SF.
    J Nutr Biochem; 2014 Oct 01; 25(10):1035-44. PubMed ID: 24998947
    [Abstract] [Full Text] [Related]

  • 7. The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.
    Nai A, Pellegrino RM, Rausa M, Pagani A, Boero M, Silvestri L, Saglio G, Roetto A, Camaschella C.
    Haematologica; 2014 Jun 01; 99(6):1016-21. PubMed ID: 24658816
    [Abstract] [Full Text] [Related]

  • 8. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
    Nai A, Rubio A, Campanella A, Gourbeyre O, Artuso I, Bordini J, Gineste A, Latour C, Besson-Fournier C, Lin HY, Coppin H, Roth MP, Camaschella C, Silvestri L, Meynard D.
    Blood; 2016 May 12; 127(19):2327-36. PubMed ID: 26755707
    [Abstract] [Full Text] [Related]

  • 9. Hepcidin is involved in iron regulation in the ischemic brain.
    Ding H, Yan CZ, Shi H, Zhao YS, Chang SY, Yu P, Wu WS, Zhao CY, Chang YZ, Duan XL.
    PLoS One; 2011 May 12; 6(9):e25324. PubMed ID: 21957487
    [Abstract] [Full Text] [Related]

  • 10. Physiological focus on the erythropoietin-hepcidin-ferroportin axis.
    D'Anna MC, Roque ME.
    Can J Physiol Pharmacol; 2013 May 12; 91(5):338-45. PubMed ID: 23656253
    [Abstract] [Full Text] [Related]

  • 11. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
    Jiang X, Gao M, Chen Y, Liu J, Qi S, Ma J, Zhang Z, Xu Y.
    Blood Cells Mol Dis; 2016 May 12; 58():45-51. PubMed ID: 27067488
    [Abstract] [Full Text] [Related]

  • 12. Effect of iron supplementation on the expression of hypoxia-inducible factor and antioxidant status in rats exposed to high-altitude hypoxia environment.
    Xu C, Dong C, Xu C, Han T, Bao S, Gao X.
    Biol Trace Elem Res; 2014 Dec 12; 162(1-3):142-52. PubMed ID: 25380676
    [Abstract] [Full Text] [Related]

  • 13. Erythropoietin administration increases splenic erythroferrone protein content and liver TMPRSS6 protein content in rats.
    Gurieva I, Frýdlová J, Rychtarčíková Z, Vokurka M, Truksa J, Krijt J.
    Blood Cells Mol Dis; 2017 May 12; 64():1-7. PubMed ID: 28282554
    [Abstract] [Full Text] [Related]

  • 14. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
    Tomczyk M, Kortas J, Flis D, Kaczorowska-Hac B, Grzybkowska A, Borkowska A, Lewicka E, Dabrowska-Kugacka A, Antosiewicz J.
    Int J Environ Res Public Health; 2020 Apr 17; 17(8):. PubMed ID: 32316587
    [Abstract] [Full Text] [Related]

  • 15. [Siwu decoction improves iron deficiency anemia in infant rats and regulates iron metabolism].
    He R, Wang HJ, Zhou Y, Li JJ, Xu XY.
    Zhongguo Zhong Yao Za Zhi; 2017 Mar 17; 42(5):944-950. PubMed ID: 28994539
    [Abstract] [Full Text] [Related]

  • 16. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
    Honda H, Kobayashi Y, Onuma S, Shibagaki K, Yuza T, Hirao K, Yamamoto T, Tomosugi N, Shibata T.
    PLoS One; 2016 Mar 17; 11(3):e0151601. PubMed ID: 26978524
    [Abstract] [Full Text] [Related]

  • 17. Effect of erythropoietin on hepcidin, DMT1 with IRE, and hephaestin gene expression in duodenum of rats.
    Kong WN, Chang YZ, Wang SM, Zhai XL, Shang JX, Li LX, Duan XL.
    J Gastroenterol; 2008 Mar 17; 43(2):136-43. PubMed ID: 18306987
    [Abstract] [Full Text] [Related]

  • 18. Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia.
    Alamo IG, Kannan KB, Smith MA, Efron PA, Mohr AM.
    J Trauma Acute Care Surg; 2016 Oct 17; 81(4):705-12. PubMed ID: 27398985
    [Abstract] [Full Text] [Related]

  • 19. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?
    Rausa M, Pagani A, Nai A, Campanella A, Gilberti ME, Apostoli P, Camaschella C, Silvestri L.
    PLoS One; 2015 Oct 17; 10(4):e0122696. PubMed ID: 25860887
    [Abstract] [Full Text] [Related]

  • 20. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.
    Robach P, Recalcati S, Girelli D, Gelfi C, Aachmann-Andersen NJ, Thomsen JJ, Norgaard AM, Alberghini A, Campostrini N, Castagna A, Viganò A, Santambrogio P, Kempf T, Wollert KC, Moutereau S, Lundby C, Cairo G.
    Blood; 2009 Jun 25; 113(26):6707-15. PubMed ID: 19264680
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.